Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.
about
Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional studyCoinfection Dynamics of Two Diseases in a Single Host Population.
P2860
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@ast
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@en
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@nl
type
label
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@ast
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@en
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@nl
prefLabel
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@ast
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@en
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@nl
P2093
P2860
P1476
Virologic and serologic outcom ...... BV coinfection in a US cohort.
@en
P2093
Judith A Aberg
Kimberly Hollabaugh
Kunling Wu
Marlene Smurzynski
Minhee Kang
Susan L Koletar
P2860
P304
P356
10.1097/QAI.0000000000000149
P407
P50
P577
2014-06-01T00:00:00Z